Valuation (41%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 35.38 | N/A |
PEG Ratio (TTM) | -1.27 | N/A |
P/S Ratio (TTM) | 0.87 | N/A |
P/B Ratio (TTM) | 0.56 | N/A |
P/FCF Ratio (TTM) | -11.34 | N/A |
Price to 5YR AVG Earnings Ratio | -41.25 | N/A |
Price to 5YR AVG FCF Ratio | 19.48 | N/A |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.29% | N/A |
ROE (TTM) | 1.59% | N/A |
Net Profit Margin (TTM) | 2.45% | N/A |
ROIC 5YR AVG | -0.26% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -69.27% | 143.32% | 35.53% |
Revenue | 309.54% | 24.52% | 11.32% |
Net Income | -71.35% | 153.22% | 35.54% |
Cash Flow | 2,225.08% | 30.41% | 1,023.13% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.32 | N/A |
Quick Ratio (TTM) | 2.73 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 1.27 | N/A |
LTL to 5YR AVG FCF | 1.48 | N/A |
Shares Outstanding Growth 5YR AVG | 4.74% | N/A |